Yet another group of mice have been cured of type 1 diabetes, this time using a combination of the drugs LSF (Lisofylline), a targeted immunosuppressant, and INGAP (Islet Neogenesis Associated Protein peptide), which promotes regrowth of pancreatic islet cells. I had heard rumors that research was being done with this kind of drug combination, but this is the first time I've found details on such a study.
In this trial, 70% of mice were shown to be cured of type 1 diabetes by this combination of drugs. By "cured", I mean that blood sugar levels remained normal even after all diabetes treatment was stopped, although I'm sure that, if this works in humans, our longer lifespan would leave us susceptible to re-onset of diabetes if we were to encounter another environmental trigger which restarted the anti-beta-cell autoimmune response.
